ArticleAntimicrobial agents and chemotherapy2020

Pharmacological Characterization of TP0591816, a Novel Macrocyclic Respiratory Syncytial Virus Fusion Inhibitor with Antiviral Activity against F Protein Mutants.

Ippei Yoshida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.